US FDA approves Currax Pharmaceuticals’ second drug manufacturing site for Contrave/Mysimba to enhance production ...
Currax Pharmaceuticals LLC, a patient-first pharma company focused on tackling the number one and number two causes of preventable death in the United States, smoking and obesity, and manufacturer of branded oral weight loss medication Contrave (naltrexone …